Taron Solutions
Chemicals & Related Products · Delaware, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20482 Old Meadow Ln, Lewes, Delaware, 19...Phone Number
(302) 827-8151Website
www.taronsolutions.comRevenue
<$5 MillionIndustry
About Taron Solutions
Taron Solutions is a bio-pharmaceutical contract development and manufacturing organization (CDMO) that offers a comprehensive range of biologic-related services, including product development and GMP manufacturing. The company specializes in accelerating the development of early biologic drugs by leveraging its extensive experience in translational research and regulatory compliance. Taron provides tailored solutions for clients, addressing various industrial challenges while ensuring efficient and cost-effective processes. Their services encompass gene modification, viral vector development, and project management for GMP manufacturing, making them a preferred partner for organizations looking to advance their biologic products.Explore more
SIC Code 28,283NAICS Code 32,325Show moreTaron Solutions Org Chart
Compare Similar Companies to Taron Solutions
Compare insights from companies similar to Taron Solutions, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Taron Solutions Tech Stack
A closer look at the technologies used by Taron Solutions
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Taron Solutions
Sign Up For FreeTo access detailed company insights
Taron Solutions is a bio-pharmaceutical contract development and manufacturing organization (CDMO) that offers a comprehensive range of biologic-related services, including product development and GMP manufacturing. The company specializes in accelerating the development of early biologic drugs by leveraging its extensive experience in translationa... Read More